Trials / Recruiting
RecruitingNCT05849129
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer: A Double Blind, Placebo Controlled, Phase II Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- The Canadian College of Naturopathic Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan to enroll 90 patients over 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ascorbic acid | High dose ascorbic acid delivered intravenously |
| OTHER | Normal Saline | 0.9% NaCl solution |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2030-10-01
- Completion
- 2031-10-01
- First posted
- 2023-05-08
- Last updated
- 2026-01-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05849129. Inclusion in this directory is not an endorsement.